Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C in Lung Transplant
NCT04505878Phase 2Withdrawn
- Sponsor
- University of Wisconsin–Madison
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ascorbic acid in primary graft dysfunction (PGD), sponsored by University of Wisconsin–Madison. Planned start Apr 2023; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
primary graft dysfunction (PGD)
Beyond the preview
Go deeper on NCT04505878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04505878.